Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,161.60
(
0.75%
)
US TECH 100
26,554.40
(
1.91%
)
Dow Jones
49,195.65
(
-0.23%
)
Brent Oil
99.56
(
-1.63%
)
Bitcoin
77,694.80
(
-0.75%
)
News Focus
News Focus
Post# of 257442
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

acgood

Send PM Follow Ignore
Followers 17
Posts 1093
Boards Moderated 0
Alias Born 05/12/2007

acgood

Re: DewDiligence post# 123990

Wednesday, 07/27/2011 12:07:24 AM

Wednesday, July 27, 2011 12:07:24 AM

Post# of 257442

Quote:
Is there any concern about the effect of TPO agonists on cancer progression and/or survival, as there is with the ESAs?
Excellent question.



Since I had to look this up, thought I would share the link:
http://www.medscape.com/viewarticle/717033

So it looks like the ESA issue only was identified from a meta analysis after the fact? I am not clear on the details/design of the promacta cancer trials to know if such an issue would likely be identified
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today